跳至主要内容
临床试验/CTRI/2024/08/072509
CTRI/2024/08/072509尚未招募4 期

Efficacy and safety of sugammadex reversal following cardiac surgery A randomized control study. - NI

Vignesh D0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Elective CABG or AVR surgeries or both .
  • ASA grade 1,2,3,4 .
  • Ejection fraction of more than or equal to 45%.

排除标准

  • Participant refusal.
  • Emergency cases.
  • Ejection fraction of less than 45%,moderate or severe RV failure .
  • CKD with moderate to severe reduced GFR (less than 30ml/min/1.73m2).
  • Participant with neuromuscular disorders.
  • History of adverse reaction to study drug.
  • Chronic opioid use.
  • BMI of more than 35kg/m2

研究者

发起方
Vignesh D

相似试验